Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 20Thoracic 4Genitourinary 3Gastrointestinal 3Breast 3Sarcoma 1Other solid neoplasm 1Head & Neck 1

Conditions

Advanced Solid Tumors 40Advanced Solid Tumor 24Solid Tumors 23Mesothelioma, Malignant 14Mesothelioma 14Solid Tumor 12Hematopoietic and Lymphatic System Neoplasm 12Ovarian Neoplasms 8Malignant Solid Neoplasm 7Pancreatic Neoplasms 6Solid Tumours 5Solid Tumor, Adult 5Neoplasms 5Colorectal Neoplasms 5Stomach Neoplasms 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumour 4Triple Negative Breast Neoplasms 3Sarcoma 3Retinoblastoma 3Kidney Neoplasms 3Advanced or Metastatic Solid Tumors 3Advanced Malignant Solid Tumors 3Advanced Malignant Solid Neoplasm 3Thymoma 2Solitary Fibrous Tumor, Pleural 2Solid Tumor Malignancies 2Solid Tumor Cancer 2Small Cell Lung Carcinoma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Other solid neoplasm × 30 days × Clear all
NCT06756035 2026-06-04

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Context Therapeutics Inc.

Phase 1 Recruiting
70 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡